Ewa Żesławska

Design of Novel and Selective Inhibitors of Urokinase-type Plasminogen Activator with Improved Pharmacokinetic Properties for Use as Antimetastatic Agents

Andrea Schweinitz, Torsten Steinmetzer, Ingo J. Banke et al. · Journal of Biological Chemistry · 2004 · 130 citations · Full text

Pharmacy, Oncology, Pharmacology +15

Crystals of the urokinase type plasminogen activator variant βc-uPA in complex with small molecule inhibitors open the way towards structure-based drug design 1 1Edited by A. Fersht

Ewa Żesławska, Andrea Schweinitz, Annette Kärcher et al. · Journal of Molecular Biology · 2000 · 72 citations · Full text

Pharmacy, Medicinal Chemistry, Drug Design +7

The 5-aromatic hydantoin-3-acetate derivatives as inhibitors of the tumour multidrug resistance efflux pump P-glycoprotein (ABCB1): Synthesis, crystallographic and biological studies

Ewa Żesławska, Annamária Kincses, Gabriella Spengler et al. · Bioorganic & Medicinal Chemistry · 2016 · 39 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Crystals of Urokinase Type Plasminogen Activator Complexes Reveal the Binding Mode of Peptidomimetic Inhibitors

Ewa Żesławska, Uwe Jacob, Andrea Schweinitz et al. · Journal of Molecular Biology · 2003 · 34 citations

Life Sciences, Medicinal Chemistry, Pharmacology +14

Pronounced activity of aromatic selenocyanates against multidrug resistant ESKAPE bacteria

Muhammad Jawad Nasim, Karolina Witek, Annamária Kincses et al. · New Journal of Chemistry · 2019 · 34 citations · Full text

Life Sciences, Microbiology, Pharmacology +5